Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-07-03FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) from Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection [Phase 3]
Phase 3 trial evaluating entecavir/pegylated interferon in immune-tolerant children with chronic hepatitis B; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B [Phase 3]
Phase 3 trial investigating combination entecavir and peginterferon for HBeAg-positive immune-tolerant adults with chronic hepatitis B; stud…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy [Phase 2]
The Phase 2 study of ARB-001467 in chronic hepatitis B patients receiving nucleos(t)ide therapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects [Phase 1]
A Phase 1 study evaluating the safety and pharmacokinetics of a new extended-release formulation of entecavir in healthy subjects has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers [NA]
This clinical trial from Peking University First Hospital aims to reverse hepatic fibrosis or cirrhosis related to hepatitis B and to identi…
-
FDA approval · 2018-06-22FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, LLC.
-
FDA approval · 2018-06-22FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA has approved a supplemental application for BARACLUDE (entecavir) by E.R. Squibb & Sons, L.L.C., indicating an update to the product…
-
CLINICAL_TRIALS research · 2018-06-21Clinical Trial Update: Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance
A clinical trial update examining switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients with…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Characterisation of Human B Cell Maturation in Response to Vaccination
A completed clinical trial update characterising how human B cells mature in response to Hepatitis B vaccination, conducted by Imperial Coll…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Crowdsourcing to Promote HBV and HCV Testing in China [NA]
The UNC-Chapel Hill-sponsored trial NCT03482388, a crowdsourcing initiative to promote HBV and HCV testing in China, has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
This Phase 2 trial assessed RO6864018 in virologically suppressed participants with chronic hepatitis B; the study has completed.
-
CLINICAL_TRIALS research · 2018-05-29Clinical Trial Update: Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants
An observational study by Nanfang Hospital / Southern Medical University examines pregnant women with chronic hepatitis B and the health out…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg [Phase 4]
This document provides a Phase 4 clinical trial update on optimizing Peginterferon alpha treatment in chronic hepatitis B patients with low …
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients [Phase 4]
This clinical trial update reports on a Phase 4 study in chronic hepatitis B patients with low replicative infection, focusing on HBsAg loss…
-
CLINICAL_TRIALS research · 2018-05-21Clinical Trial Update: Assessment of Liver Fibrosis and Prognosis in Chinese Patients With CHB Infection Using STE/STQ Elastography
This clinical trial update reports on evaluating liver fibrosis and prognosis in Chinese patients with chronic hepatitis B infection using S…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis [Phase 3]
A Phase III trial evaluating two Hepatitis B vaccination schemes in patients with hepatic cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B [Phase 4]
A Phase 4 trial compares tenofovir alone versus tenofovir plus entecavir in patients with entecavir-resistant chronic hepatitis B and has co…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients [Phase 4]
Phase 4 trial evaluating combination therapy with interferon, interleukin-2, and hepatitis B vaccine in chronic hepatitis B patients has com…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection [Phase 4]
A Phase 4 clinical trial update reports completion of a study evaluating intensified schedule therapeutic vaccination in combination with Pe…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Optimizing HBV Management During Anti-CD20 Antibodies
This clinical trial update from The University of Hong Kong discusses optimizing management of Hepatitis B in patients receiving anti-CD20 a…
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France
This clinical trial update describes a strategic screening initiative for HIV, Hepatitis B, Hepatitis C, and Tuberculosis among migrants in …
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial [NA]
A completed multi-center randomized open-label trial evaluating the curative effect of combining entecavir with resveratrol in hepatitis B p…
-
CLINICAL_TRIALS research · 2018-04-26Clinical Trial Update: French HIV-HBV Cohort
This entry notes an ongoing French HIV-HBV cohort clinical trial sponsored by Institut de Médecine et d'Epidémiologie Appliquée, studying pa…
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B [Phase 4]
This document reports a Phase 4 real-world study update evaluating pegylated interferon in nucleoside-treated patients with chronic hepatiti…